High-yield production of L-valine in engineered Escherichia coli by a novel two-stage fermentation

Yanan Hao,Qian Ma,Xiaoqian Liu,Xiaoguang Fan,Jiaxuan Men,Heyun Wu,Shuai Jiang,Daoguang Tian,Bo Xiong,Xixian Xie
DOI: https://doi.org/10.1016/j.ymben.2020.09.007
IF: 8.4
2020-11-01
Metabolic Engineering
Abstract:<p>L-valine is an essential amino acid and an important amino acid in the food and feed industry. The relatively low titer and low fermentation yield currently limit the large-scale application of L-valine. Here, we constructed a chromosomally engineered <em>Escherichia coli</em> to efficiently produce L-valine. First, the synthetic pathway of L-valine was enhanced by heterologous introduction of a feedback-resistant acetolactate acid synthase from <em>Bacillus subtilis</em> and overexpression of other two enzymes in the L-valine synthetic pathway. For efficient efflux of L-valine, an exporter from <em>Corynebacterium glutamicum</em> was subsequently introduced. Next, the precursor pyruvate pool was increased by knockout of GTP pyrophosphokinase and introduction of a ppGpp 3′-pyrophosphohydrolase mutant to facilitate the glucose uptake process. Finally, in order to improve the redox cofactor balance, acetohydroxy acid isomeroreductase was replaced by a NADH-preferring mutant, and branched-chain amino acid aminotransferase was replaced by leucine dehydrogenase from <em>Bacillus subtilis</em>. Redox cofactor balance enabled the strain to synthesize L-valine under oxygen-limiting condition, significantly increasing the yield in the presence of glucose. Two-stage fed-batch fermentation of the final strain in a 5 L bioreactor produced 84 g/L L-valine with a yield and productivity of 0.41 g/g glucose and 2.33 g/L/h, respectively. To the best of our knowledge, this is the highest L-valine titer and yield ever reported in <em>E. coli</em>. The systems metabolic engineering strategy described here will be useful for future engineering of <em>E. coli</em> strains for the industrial production of L-valine and related products.</p>
biotechnology & applied microbiology
What problem does this paper attempt to address?